A detailed history of Deka Bank Deutsche Girozentrale transactions in Zoetis Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 332,878 shares of ZTS stock, worth $56.7 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
332,878
Previous 332,878 -0.0%
Holding current value
$56.7 Million
Previous $64.6 Million 16.03%
% of portfolio
0.1%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$172.58 - $196.48 $1.01 Million - $1.15 Million
-5,836 Reduced 1.72%
332,878 $64.6 Million
Q2 2024

Aug 08, 2024

SELL
$145.54 - $178.83 $4.61 Million - $5.67 Million
-31,708 Reduced 8.56%
338,714 $59 Million
Q1 2024

Apr 24, 2024

SELL
$165.67 - $199.94 $1.86 Million - $2.25 Million
-11,255 Reduced 2.95%
370,422 $63.3 Million
Q4 2023

Jan 24, 2024

SELL
$151.44 - $200.09 $1.37 Million - $1.81 Million
-9,031 Reduced 2.31%
381,677 $74.5 Million
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $1.62 Million - $1.87 Million
-9,678 Reduced 2.42%
390,708 $67.6 Million
Q2 2023

Jul 25, 2023

BUY
$160.94 - $186.23 $4.99 Million - $5.78 Million
31,021 Added 8.4%
400,386 $68.1 Million
Q1 2023

Apr 24, 2023

BUY
$145.48 - $175.02 $3.03 Million - $3.65 Million
20,842 Added 5.98%
369,365 $60 Million
Q4 2022

Feb 01, 2023

SELL
$131.14 - $157.47 $6.67 Million - $8.01 Million
-50,863 Reduced 12.74%
348,523 $51.3 Million
Q3 2022

Nov 02, 2022

BUY
$148.29 - $182.55 $11.3 Million - $13.9 Million
76,381 Added 23.65%
399,386 $59.8 Million
Q2 2022

Aug 03, 2022

SELL
$155.97 - $200.09 $3.08 Million - $3.95 Million
-19,739 Reduced 5.76%
323,005 $55.4 Million
Q1 2022

Apr 28, 2022

BUY
$181.39 - $234.03 $11.5 Million - $14.9 Million
63,460 Added 22.72%
342,744 $65.8 Million
Q4 2021

Feb 02, 2022

BUY
$193.69 - $247.03 $5.55 Million - $7.08 Million
28,662 Added 11.44%
279,284 $69.3 Million
Q3 2021

Oct 22, 2021

SELL
$189.29 - $209.69 $9.84 Million - $10.9 Million
-51,967 Reduced 17.17%
250,622 $48.8 Million
Q2 2021

Aug 05, 2021

BUY
$155.9 - $187.99 $7.41 Million - $8.93 Million
47,520 Added 18.63%
302,589 $57.1 Million
Q1 2021

Apr 28, 2021

BUY
$144.0 - $169.39 $4.33 Million - $5.1 Million
30,101 Added 13.38%
255,069 $39.7 Million
Q4 2020

Mar 12, 2021

BUY
$157.07 - $174.35 $979,645 - $1.09 Million
6,237 Added 2.85%
224,968 $36.5 Million
Q3 2020

Oct 29, 2020

BUY
$137.1 - $165.37 $11.6 Million - $14 Million
84,810 Added 63.33%
218,731 $34.9 Million
Q2 2020

Aug 04, 2020

SELL
$111.92 - $142.53 $1.45 Million - $1.85 Million
-12,959 Reduced 8.82%
133,921 $17.5 Million
Q1 2020

May 14, 2020

SELL
$92.66 - $144.94 $1.14 Million - $1.78 Million
-12,304 Reduced 7.73%
146,880 $16.8 Million
Q4 2019

Feb 04, 2020

SELL
$116.25 - $133.25 $12.9 Million - $14.8 Million
-110,964 Reduced 41.08%
159,184 $21.1 Million
Q3 2019

Nov 14, 2019

SELL
$112.57 - $128.43 $26.2 Million - $29.9 Million
-232,824 Reduced 46.29%
270,148 $33.6 Million
Q2 2019

Aug 01, 2019

BUY
$97.98 - $114.28 $7.33 Million - $8.55 Million
74,854 Added 17.48%
502,972 $56.9 Million
Q1 2019

May 10, 2019

BUY
$81.56 - $100.67 $3.26 Million - $4.02 Million
39,910 Added 10.28%
428,118 $38.6 Million
Q4 2018

Feb 12, 2019

SELL
$79.28 - $95.27 $3.16 Million - $3.8 Million
-39,910 Reduced 9.32%
388,208 $32.9 Million
Q3 2018

Nov 09, 2018

SELL
$83.5 - $93.23 $2.8 Million - $3.13 Million
-33,569 Reduced 7.27%
428,118 $0
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $3 Million - $3.35 Million
-37,591 Reduced 7.53%
461,687 $39.3 Million
Q1 2018

May 03, 2018

BUY
$71.51 - $84.69 $13.3 Million - $15.7 Million
185,622 Added 59.18%
499,278 $40.7 Million
Q3 2017

Nov 06, 2017

BUY
$59.73 - $65.4 $18.7 Million - $20.5 Million
313,656
313,656 $19.4 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $79.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.